A case of insulinoma with hypoglycemia that was better managed with lanreotide than octreotide
Abstract Long‐acting somatostatin analogs, including lanreotide slow release (LAN‐SR) and octreotide long‐acting release (OCT‐LAR), can improve hypoglycemia in insulinoma. LAN‐SR may be more beneficial in some patients with insulinoma than OCT‐LAR.
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-05-01
|
| Series: | Clinical Case Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ccr3.4118 |
| id |
doaj-c8f36da7f51346be9985853c6f2c1c3d |
|---|---|
| record_format |
Article |
| spelling |
doaj-c8f36da7f51346be9985853c6f2c1c3d2021-06-04T10:35:48ZengWileyClinical Case Reports2050-09042021-05-0195n/an/a10.1002/ccr3.4118A case of insulinoma with hypoglycemia that was better managed with lanreotide than octreotideKeiko Yamaoka0Shuichi Nagashima1Nobukazu Okada2Nagisa Sawayama3Shinsuke Saito4Manabu Takahashi5Kenta Okada6Kazuhiro Endo7Masaru Koizumi8Hideki Sasanuma9Ken Ebihara10Atsuko Kasajima11Noriyoshi Fukushima12Naohiro Sata13Shun Ishibashi14Division of Endocrinology and Metabolism Department of Medicine Jichi Medical University Shimotsuke JapanDivision of Endocrinology and Metabolism Department of Medicine Jichi Medical University Shimotsuke JapanDivision of Endocrinology and Metabolism Department of Medicine Jichi Medical University Shimotsuke JapanDivision of Endocrinology and Metabolism Department of Medicine Jichi Medical University Shimotsuke JapanDivision of Endocrinology and Metabolism Department of Medicine Jichi Medical University Shimotsuke JapanDivision of Endocrinology and Metabolism Department of Medicine Jichi Medical University Shimotsuke JapanDivision of Endocrinology and Metabolism Department of Medicine Jichi Medical University Shimotsuke JapanDepartment of Surgery Jichi Medical University Shimotsuke JapanDepartment of Surgery Jichi Medical University Shimotsuke JapanDepartment of Surgery Jichi Medical University Shimotsuke JapanDivision of Endocrinology and Metabolism Department of Medicine Jichi Medical University Shimotsuke JapanDepartment of Pathology Tohoku University Graduate School of Medicine Sendai JapanDepartment of Pathology Jichi Medical University Shimotsuke JapanDepartment of Surgery Jichi Medical University Shimotsuke JapanDivision of Endocrinology and Metabolism Department of Medicine Jichi Medical University Shimotsuke JapanAbstract Long‐acting somatostatin analogs, including lanreotide slow release (LAN‐SR) and octreotide long‐acting release (OCT‐LAR), can improve hypoglycemia in insulinoma. LAN‐SR may be more beneficial in some patients with insulinoma than OCT‐LAR.https://doi.org/10.1002/ccr3.4118hypoglycemiainsulinomalanreotideoctreotidesomatostatin analog |
| collection |
DOAJ |
| language |
English |
| format |
Article |
| sources |
DOAJ |
| author |
Keiko Yamaoka Shuichi Nagashima Nobukazu Okada Nagisa Sawayama Shinsuke Saito Manabu Takahashi Kenta Okada Kazuhiro Endo Masaru Koizumi Hideki Sasanuma Ken Ebihara Atsuko Kasajima Noriyoshi Fukushima Naohiro Sata Shun Ishibashi |
| spellingShingle |
Keiko Yamaoka Shuichi Nagashima Nobukazu Okada Nagisa Sawayama Shinsuke Saito Manabu Takahashi Kenta Okada Kazuhiro Endo Masaru Koizumi Hideki Sasanuma Ken Ebihara Atsuko Kasajima Noriyoshi Fukushima Naohiro Sata Shun Ishibashi A case of insulinoma with hypoglycemia that was better managed with lanreotide than octreotide Clinical Case Reports hypoglycemia insulinoma lanreotide octreotide somatostatin analog |
| author_facet |
Keiko Yamaoka Shuichi Nagashima Nobukazu Okada Nagisa Sawayama Shinsuke Saito Manabu Takahashi Kenta Okada Kazuhiro Endo Masaru Koizumi Hideki Sasanuma Ken Ebihara Atsuko Kasajima Noriyoshi Fukushima Naohiro Sata Shun Ishibashi |
| author_sort |
Keiko Yamaoka |
| title |
A case of insulinoma with hypoglycemia that was better managed with lanreotide than octreotide |
| title_short |
A case of insulinoma with hypoglycemia that was better managed with lanreotide than octreotide |
| title_full |
A case of insulinoma with hypoglycemia that was better managed with lanreotide than octreotide |
| title_fullStr |
A case of insulinoma with hypoglycemia that was better managed with lanreotide than octreotide |
| title_full_unstemmed |
A case of insulinoma with hypoglycemia that was better managed with lanreotide than octreotide |
| title_sort |
case of insulinoma with hypoglycemia that was better managed with lanreotide than octreotide |
| publisher |
Wiley |
| series |
Clinical Case Reports |
| issn |
2050-0904 |
| publishDate |
2021-05-01 |
| description |
Abstract Long‐acting somatostatin analogs, including lanreotide slow release (LAN‐SR) and octreotide long‐acting release (OCT‐LAR), can improve hypoglycemia in insulinoma. LAN‐SR may be more beneficial in some patients with insulinoma than OCT‐LAR. |
| topic |
hypoglycemia insulinoma lanreotide octreotide somatostatin analog |
| url |
https://doi.org/10.1002/ccr3.4118 |
| work_keys_str_mv |
AT keikoyamaoka acaseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT shuichinagashima acaseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT nobukazuokada acaseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT nagisasawayama acaseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT shinsukesaito acaseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT manabutakahashi acaseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT kentaokada acaseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT kazuhiroendo acaseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT masarukoizumi acaseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT hidekisasanuma acaseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT kenebihara acaseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT atsukokasajima acaseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT noriyoshifukushima acaseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT naohirosata acaseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT shunishibashi acaseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT keikoyamaoka caseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT shuichinagashima caseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT nobukazuokada caseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT nagisasawayama caseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT shinsukesaito caseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT manabutakahashi caseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT kentaokada caseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT kazuhiroendo caseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT masarukoizumi caseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT hidekisasanuma caseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT kenebihara caseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT atsukokasajima caseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT noriyoshifukushima caseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT naohirosata caseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide AT shunishibashi caseofinsulinomawithhypoglycemiathatwasbettermanagedwithlanreotidethanoctreotide |
| _version_ |
1721397632228655104 |